Swiss pharmaceutical leader Roche has revealed its intention to invest 2.04 billion yuan in the construction of a new biopharmaceutical manufacturing facility in Shanghai, enhancing its localization strategy within the Chinese market.
Copyright(c) 2025 Sky News All Right Reserved